Indonex Health Analytics Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 20.00 K
- Company Age 8 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 11.57%
- Profit Growth -71.54%
- Ebitda -12.90%
- Net Worth 19.59%
- Total Assets 65.55%
About Indonex Health Analytics
Indonex Health Analytics Private Limited (IHAPL) is a Private Limited Indian Non-Government Company incorporated in India on 05 August 2016 (Eight years and six months 6 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 20.00 K , as per Ministry of Corporate Affairs (MCA) records.
Venkateswara Pydah and Ratnavathi Pydah serve as directors at the Company.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U72900TG2016PTC111328
-
Company No.
111328
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
05 Aug 2016
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Indonex Health Analytics?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Venkateswara Pydah
|
Director | 05-Aug-2016 | Current |
|
Ratnavathi Pydah
|
Director | 05-Aug-2016 | Current |
Financial Performance of Indonex Health Analytics.
Indonex Health Analytics Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 11.57% increase. The company also saw a substantial fall in profitability, with a 71.54% decrease in profit. The company's net worth Soared by an impressive increase of 19.59%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Indonex Health Analytics?
In 2021, Indonex Health Analytics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Rxshopy India Private LimitedVenkateswara Pydah is a mutual person
-
Vasavi Prosoft Transcription Private LimitedVenkateswara Pydah is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Indonex Health Analytics?
Indonex Health Analytics has a workforce of 39 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Indonex Health Analytics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Indonex Health Analytics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.